|
Status |
Public on Feb 20, 2009 |
Title |
SLE5-TC |
Sample type |
RNA |
|
|
Source name |
T cells
|
Organism |
Homo sapiens |
Characteristics |
>95% CD3+ T cells negatively isolated with Dynal kit from SLE patient
|
Treatment protocol |
Unstimulated
|
Extracted molecule |
total RNA |
Extraction protocol |
RNeasy (Qiagen)
|
Label |
Biotin
|
Label protocol |
Standard Affymetrix Two Cycle IVT Protocol
|
|
|
Hybridization protocol |
Standard Affymetrix FS450_0001
|
Scan protocol |
Affymetrix GeneChip Scanner 7G Plus
|
Description |
Additional details provided in accompanying manuscript, SLE5-TC
|
Data processing |
MAS5/GCOS
|
|
|
Submission date |
Dec 09, 2008 |
Last update date |
Aug 28, 2018 |
Contact name |
Frank A Middleton |
E-mail(s) |
middletf@upstate.edu
|
Phone |
315-464-7721
|
Organization name |
SUNY Upstate Medical Univ
|
Department |
Neuroscience and Physiology
|
Street address |
505 Irving Avenue
|
City |
Syracuse |
State/province |
NY |
ZIP/Postal code |
13210 |
Country |
USA |
|
|
Platform ID |
GPL570 |
Series (1) |
GSE13887 |
Activation of mTOR controls the loss of TCRζ in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation |
|
Relations |
Reanalyzed by |
GSE119087 |